Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11485520 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
Conditions: Metastatic Liver Cancer;   Secondary Liver Cancer;   Liver Neoplasm
Interventions: Device: Radiofrequency Ablation (RFA);   Drug: Chemotherapy

Indicates status has not been verified in more than two years